US painkiller restriction linked to increase in drug trading

June 14, 2018, Swinburne University of Technology
US painkiller restriction linked to increase in drug trading
Researchers analysed the effect of restrictions on opioid painkillers prescriptions in the U.S. Credit: Swinburne University of Technology

A new study led by Swinburne shows trading of prescription opioids through the darknet has increased in the wake of tighter regulation by the US government for this category of legal pharmaceutical products prescribed by doctors.

In the study published by the BMJ and conducted by Swinburne, University of Kent, Université de Montréal and University of Manchester, researchers analysed the effects of the Drug Enforcement Administration (DEA) 2014 restriction in how hydrocodone combination products (HCP) were prescribed by doctors.

"Hydrocodone was the most popularly prescribed in the United States, and its use, along with oxycodone, has been implicated as one of the major drivers of the US opioid crisis," says lead researcher at Swinburne, Associate Professor in Criminology, Dr. James Martin.

"In order to combat misuse, in October 2014, the DEA moved painkillers containing hydrocodone from Schedule III to the more restrictive Schedule II category, making the significantly harder to obtain from medical professionals."

An increase in illicit trading

Professor Judith Aldridge from the University of Manchester says, "While these changes have been shown to reduce the available supply of these medications through legitimate channels, what is less well understood is whether users may seek out illicit supplies via illegal markets in response."

"Our study used data obtained from 31 of the world's largest so-called 'darknet' drug markets in operation up until last year. We were therefore able to identify some of the unanticipated consequences of restricting drug supplies in a context of high consumer demand," says Dr. Jack Cunliffe, Lecturer at the University of Kent.

The study found that after the introduction of the DEA's regulations, illicit trading of these substances increased by around 4 percentage points a year, meaning the amount of trade that represent in the US doubled over the study period. There were no significant changes to other categories of pharmaceutical drugs, including stimulants such as modafinil, or sedatives such as Diazepam and Xanax.

"We found that in the period immediately following DEA's new regulations there was a rise in the proportion of US cryptomarket drug trade attributable to prescription opioids," says Dr. Martin.

"Our study provides solid empirical evidence that restricting the legal supply of hydrocodone in the US was correlated with a significant, sustained increase in people sourcing illicit opioids from the black market, in this case anonymous drug marketplaces on the darknet."

Solving the opioid crisis

Dr. Martin says the opioid crisis is the biggest public health emergency currently facing the US.

"Our research indicates that in order to effectively tackle this health problem, other policy responses, such as demand and harm reduction, are necessary, rather focusing on supply reduction alone."

Dr. David Décary-Hétu at Université of Montréal in Canada also urges people not to interpret this study as a suggestion that the darknet is fuelling the US crisis.

"We would argue against this interpretation; our research indicates that trading of illicit opioids on the darknet is demand-driven, meaning that darknet drug traders are responding to existing demand for illicit opioids, rather than creating the demand in the first place," says Dr. Décary-Hétu.

Explore further: US painkiller restriction linked to 'significant' increase in illicit online drug trading

More information: James Martin et al. Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis, BMJ (2018). DOI: 10.1136/bmj.k2270

Related Stories

US painkiller restriction linked to 'significant' increase in illicit online drug trading

June 13, 2018
The US Drug Enforcement Administration's decision to restrict prescription drugs containing hydrocodone (a popular opioid painkiller) was associated with a 'significant' increase in illicit trading of opioids through online ...

Nearly one in three people know someone addicted to opioids

May 8, 2018
The opioid crisis continues to weigh heavily on the minds of Americans, according to a new national poll released today by the American Psychiatric Association, (APA). Nearly a third of Americans say they know someone who ...

US doctors prescribing fewer opioid painkillers: report

May 31, 2018
US doctors reduced the number of prescriptions for opioid painkillers last year, continuing a five-year trend, in an effort to reverse a deadly drug abuse epidemic, a report released Thursday said.

Policy changes reduced use of certain prescription opioids: study

August 1, 2017
(HealthDay)—Tighter U.S. government restrictions on prescription painkillers containing hydrocodone led to reduced use of opioid medications such as Vicodin, a new study says.

Opioid-related hospitalizations rising in Medicare patients without opioid prescriptions

April 18, 2018
A 2014 federal change that limited the dispensing of hydrocodone products may be indirectly contributing to the illegal use of some of those drugs, a study by University of Texas Medical Branch researchers has found.

Recommended for you

Discovery opens door for synthetic opioids with less addictive qualities

June 1, 2018
Making opioids from sugar instead of from field grown opium poppies has the potential to solve many of the problems associated with manufacturing strong pain killers.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.